Alerts will be sent to your verified email
Verify Email
MAHAREM
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Indo-American Advanced Pharmaceuticals Ltd focuses on manufacturing a wide range of pharmaceutical formulations including antibiotics, analgesics, and anti-inflammatory drugs such as tablets, capsules, liquids, and ointments.
IndoAmerican Advance major competitors are Chemkart India, Speciality Medicines, Accretion Pharma., Sanjivani Paranteral, Natural Capsules, Vijaypd Ceutical, Guj. Inject (Kerala).
Market Cap of IndoAmerican Advance is ₹171 Crs.
While the median market cap of its peers are ₹172 Crs.
IndoAmerican Advance seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
